Citations

Clear

4847 citation(s) found for "Yu, Eric".

Cochlear Implantation: An Overview
Deep, Nicholas L. , Dowling, Eric M. , Jethanamest, Daniel , Carlson, Matthew L. , Dowling, Eric

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | September 6, 2018 | Volume: 80 | Issue: 02 | Pages: 169-177

10.1055/s-0038-1669411 | PMID 30931225 Get It

AbstractA cochlear implant (CI) is a surgically implanted device for the treatment of severe to profound sensorineural hearing loss in children and adults. It works by transducing acoustic energy into an electrical signal, which is used to stimulate surviving spiral ganglion cells of the auditory nerve. The past 2 decades have witnessed an exponential rise in the number of CI surgeries performed. Continual developments in programming strategies, device design, and minimally traumatic surgical technique have demonstrated the safety and efficacy of CI surgery. As a result, candidacy guidelines have expanded to include both pre and postlingually deaf children as young as 1 year of age, and those with greater degrees of residual hearing. A growing proportion of patients are undergoing CI for off-label or nontraditional indications including single-sided deafness, retrocochlear hearing loss, asymmetrical sensorineural hearing loss (SNHL) in adults and children with at least 1 ear that is better than performance cut-off for age, and children less than 12 months of age. Herein, we review CI design, clinical evaluation, indications, operative technique, and outcomes. We also discuss the expanding indications for CI surgery as it relates to lateral skull base pathology, comparing CI to auditory brainstem implants, and address the concerns with obtaining magnetic resonance imaging (MRI) in CI recipients.
A phase II randomized, placebo-controlled trial evaluating nintedanib versus placebo as prophylaxis against radiation pneumonitis in patients with unresectable non-small cell lung cancer (NSCLC ) undergoing chemoradiation therapy (CRT): A National Comprehe
Dy, Grace K. , Kim, Eric S. , Baumgart, Megan , Patrick, C. , Molina, Julian R. , Adjei, Alex A. , Mattes, Malcolm David , Gadgeel, Shirish M. , Attwood, Kristopher M.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: TPS8572-TPS8572

10.1200/jco.2016.34.15_suppl.tps8572 Get It

A phase 1 study of TTI-621, a novel immune checkpoint inhibitor targeting CD47, in subjects with relapsed or refractory hematologic malignancies.
Ansell, Stephen M. , Chen, Robert W., Maris, Michael B., O’Connor, Owen A. , Wieland, Elizabeth, Flinn, Ian W. , Sievers, Eric L.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: TPS7585-TPS7585

10.1200/jco.2016.34.15_suppl.tps7585 Get It

Updated data from a phase II dose finding trial of single agent isatuximab (SAR650984, anti-CD38 mAb) in relapsed/refractory multiple myeloma (RRMM).
Martin, Thomas G. , Vij, Ravi , Cole, Craig E. , Atanackovic, Djordje , Zonder, Jeffrey A. , Bensinger, William, Zimmerman, Todd M., Lendvai, Nikoletta , Gasparetto, Cristina , Kumar, Shaji , Oprea, Corina, Richter, Joshua , Kaufman, Jonathan L. , Mıkhael, Joseph , Dimopoulos, Meletios Α. , Hari, Parameswaran , Ocio, Enrique M. , Charpentier, Éric , Strickland, Stephen Anthony , Miguel, Jesús F. San

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8005-8005

10.1200/jco.2016.34.15_suppl.8005 Get It

Outcomes in refractory aggressive diffuse large b-cell lymphoma (DLBCL): Results from the international SCHOLAR-1 study.
Crump, Michael , Neelapu, Sattva S. , Neste, Éric Van Den, Ahmed, Mohamed , Zhu, Liting , Feng, Lei, Navale, Lynn, Wiezorek, Jeffrey S., Go, William Y., Gisselbrecht, Christian , Farooq, Umar , Kuruvilla, John , Link, Brian K. , Hay, Annette E. , Cerhan, James R. , Boussetta, Sami , Maurer, Matthew J.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 7516-7516

10.1200/jco.2016.34.15_suppl.7516 Get It

Validation of a genomic risk classifier to predict prostate cancer-specific mortality (PCSM) in high-risk patients.
Karnes, Jeffrey , Ross, Ashley E. , Erho, Nicholas , Yousefi, Kasra, Takhar, Mandeep, Schaeffer, Edward M. , Klein, Eric A. , Davicioni, Elai , Trock, Bruce J

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 5056-5056

10.1200/jco.2016.34.15_suppl.5056 Get It

HSD3B1 and resistance to androgen deprivation therapy in prostate cancer.
AbuAli, Ghada, Reichard, Chad A. , Chang, Kai‐Hsiung , Carlson, Rachel E. , Rangel, Laureano J. , Reagan, Kevin, Davis, Brian A., Karnes, Jeffrey , Tindall, Donald J., Sharifi, Nima , Hearn, Jason W.D. , Reddy, Chandana A. , Magi‐Galluzzi, Cristina , Davis, Brian, Kohli, Manish , Klein, Eric A.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 5015-5015

10.1200/jco.2016.34.15_suppl.5015 Get It

NETTER-1 phase III: Efficacy and safety results in patients with midgut neuroendocrine tumors treated with 177Lu-DOTATATE.
Wolin, Edward M. , Chasen, Beth, Kulke, Matthew H. , Caplin, Martyn , Baum, Richard P. , Hobday, Timothy J. , Hendifar, Andrew , Öberg, Kjell E., Sierra, Maribel Lopera , Kwekkeboom, Dik J., Ruszniewski, Philippe, Krenning, Eric P. , Kunz, Pamela L. , Strosberg, Jonathan , Bushnell, David

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 4005-4005

10.1200/jco.2016.34.15_suppl.4005 Get It

Regorafenib in previously treated metastatic colorectal cancer (mCRC): Analysis of age subgroups in the open-label phase IIIb CONSIGN trial.
Seitz, Jean François, Hofheinz, Ralf‐Dieter , Arriaga, Yull , Verma, Udit, Grothey, Axel, Miriyala, Ashok, Kalmus, J., Kappeler, Christian, Zaniboni, Alberto , Cutsem, Eric Van , Ciardiello, Fortunato , Ychou, Marc , García‐Carbonero, Rocio , Falcone, Alfredo

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 3524-3524

10.1200/jco.2016.34.15_suppl.3524 Get It

Validity of Adjuvant! Online in elderly patients with stage III colon cancer based on 2,794 patients from the ACCENT database.
Matthaiou, Christiana , Renfro, Lindsay A. , Papamichael, Demetris , O’Connell, Michael, Guthrie, Katherine A. , Haller, Daniel G. , Kountourakis, P., Yothers, Greg , Saltz, Leonard B. , Cutsem, Eric Van , Schmoll, Hans‐Joachim , Labianca, Roberto , André, Thierry , Alberts, Steven R. , Sargent, Daniel J.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 3620-3620

10.1200/jco.2016.34.15_suppl.3620 Get It